⟵ Back to Search Results
BGB-A317-303

Active, not recruiting

Comparison of Efficacy and Safety of Anti-PD-1 Antibody BGB-A317 Versus Docetaxel as Treatment in the Second- or Third-line Setting in Participants With NSCLC

Beigene Study ID info

BGB-A317-303

ClinicalTrials.gov ID info

NCT03358875

EudraCT Number info

2018-000245-39

Clinical Drug Trials ID info

CTR20171112

Study Overview

Sex: All

Age: 18 Years and older   (Adult, Older Adult)

No Study Documents

Study Overview

Sex: All

Age: 18 Years and older   (Adult, Older Adult)

No Study Documents